Notably, gain-of-function PPM1D mutations are frequently observed in thyroid carcinomas and other cancer types, often in a mutually exclusive fashion with TP53 mutations, suggesting that PPM1D-mediated suppression of p53 activity is a common feature across diverse malignancies2,35–40. This evidence concerns the gene PPM1D and thyroid gland carcinoma.